Clinical trials
Observational Dermatitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Recruiting | 5 |
| Unknown status | 5 |
| Not yet recruiting | 2 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Bitop AG | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Pfizer | 2 |
| AI Labs Group S.L | 1 |
| Central Hospital, Nancy, France | 1 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
| Centre Hospitalier de Valenciennes | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Guy's and St Thomas' NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dermatitis | 36 |
| Dermatitis, Atopic | 8 |
| Eczema | 8 |
| Skin Diseases | 7 |
| Psoriasis | 6 |
| Breast Neoplasms | 3 |
| Hypersensitivity | 3 |
| Urticaria | 3 |
| Acne Vulgaris | 2 |
| Dermatitis, Contact | 2 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.